Bliss GVS Pharma Limited has informed the Exchange regarding Resignation of Mrs Shruti Vishal Rao as Executive Director of the company w.e.f. close of business of February 10, 2026.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mrs Shruti Vishal Rao has resigned from her position as Executive Director of Bliss GVS Pharma Limited, with the resignation taking effect from the close of business on February 10, 2026. An Executive Director is a member of the company's board and is classified as a Key Managerial Personnel (KMP) under Indian company law. The company has informed the stock exchange about this development. No successor or replacement has been mentioned in this filing.
The departure of a board-level executive may lead to short-term governance uncertainty, but the impact on stock price is likely limited unless it signals deeper management instability. Shareholders should watch for any follow-up announcement regarding a replacement appointment.